À compter du 1er décembre 2023, l’accès à POEMs et à Essential Evidence Plus ne fera plus partie des avantages offerts aux membres de l’AMC.
Question clinique
As compared with continued intravenous therapy, is oral step-down antibiotic therapy associated with worse outcomes in the treatment of gram-negative bacteremia?
L’Essentiel
For patients with gram-negative bacteremia who have achieved source control and have shown an appropriate clinical response to treatment, transition from intravenous antibiotics to oral antibiotics to complete the treatment course is not associated with increased 30-day mortality or recurrence of bacteremia and is associated with a 2-day shorter duration of stay. 2b
Référence
Plan de l'etude: Cohort (retrospective)
Financement: Government
Cadre: Inpatient (any location) with outpatient follow-up
Sommaire
Using electronic medical records, researchers identified hospitalized adult patients from 3 academic medical centers over 6 years who had monomicrobial Enterobacteriaceae gram-negative bacteremia. Eligible patients were those who had achieved source control, had an appropriate clinical response by day 5 of treatment, had the ability to tolerate oral medications, and had an active oral antibiotic agent that could be used for treatment. The study compared those who transitioned to oral step-down antibiotic therapy within 5 days of treatment (n = 876) with those who received a full course of intravenous antibiotic therapy (n = 1285). At baseline, the patients in the oral step-down therapy group were less likely to be severely ill at the onset of the infection (based on intensive care unit admission on day 1 and Pitt bacteremia score) and were more likely to have an infection due to a urinary tract source. Treatment duration ranged from 7 days to 15 days in both groups. After propensity-score matching using factors such as source of infection, pre-exisiting illnesses, and immunocompromised status, 739 patients in each study arm were matched. There were no significant differences detected in 30-day mortality or 30-day recurrence of bacteremia when comparing the 2 matched groups. The oral step-down group had a significantly shorter duration of hospital stay from day 1 of bacteremia to discharge (5 days vs 7 days; P <.001).
Reviewer
Nita Shrikant Kulkarni, MD
Assistant Professor in Hospital Medicine
Northwestern University
Chicago, IL